Get notified when ACH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisting (new) — The company received NYSE notice of non-compliance with minimum price and market cap requirements and plans a reverse stock split.
- Goodwill Impairment (removed) — The prior-year $106 million goodwill impairment charge is absent because the P&HS business was sold.
Accendra Health posts $19.7M net loss as revenue falls 13.7% to $601.8M
Filed November 6, 2026 · Period ending September 30, 2026 · Compared to 10-Q Oct 31, 2025 · ~1 min read
Key Changes
-
high
Net loss narrowed 86.9% to $19.7M, but operating income fell 95% to $1.3M — the improvement came from below the operating line, not operations.
MD&A: Results verify on EDGAR → -
high
Revenue declined 13.7% to $601.8M, driven by the loss of a major commercial payor contract and the P&HS divestiture.
MD&A: Revenue verify on EDGAR → -
high
Completed a debt restructuring in June 2026, exchanging unsecured notes for 9.000% and 9.750% secured notes, raising interest expense 29.6%.
MD&A: Debt verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (OWL 10-Q) is open in full — no account needed.
Partner
Trade ACH commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Nov 9, 2026 · How we verify